17 December 2024

Alcohol Obesity Pharmaceuticals

Weight loss drugs cut alcohol use

17 December 2024

Diabetes Obesity

Even more things GLP-1 RAs can do

19 November 2024

Diabetes Obesity Pharmaceuticals

Tirzepatide safe, highly effective for three years

22 October 2024

Cancer Obesity

Obesity raises risk of second cancers in survivors

24 September 2024

Dermatology Obesity

Obese kids risk eczema, psoriasis, alopecia

27 August 2024

Obesity Pharmaceuticals Surgery

Bariatric surgery declining amid rise of GLP-1 RAs

27 August 2024

Diabetes Obesity

‘Exciting’ discovery on metabolic disease triggers

4 June 2024

Clinical Obesity

BMI of 27 equals obesity in over-40s

4 June 2024

Diabetes Gastroenterology Obesity Pharmaceuticals

‘Significant issue’: surgical risks of GLP-1 RAs

9 May 2024

Obesity Paediatrics

Iron deficiency risk increases in overweight and obese children

6 May 2024

Obesity Public Health

Tiny portion of health funding allocated for obesity prevention

5 May 2024

Obesity Pharmacy

‘Turbocharged’ $160bn market for obesity drugs by 2030